Seminars in Cancer Biology (YSCBI) is a review journal dedicated to keeping scientists informed of developments in the field of molecular oncology. Each issue is thematic in approach, devoted to an important topic of interest to cancer biologists, from the underlying genetic and molecular causes of cellular transformation and cancer to the molecular basis of potential therapies. Every issue is edited by a guest editor or editors, an internationally acknowledged expert(s) in the field and contains approximately eight to twelve authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area.

The journal publishes topics including:
Role of glycation in different types of cancer
Immuno-Oncological Biomarkers
Epigenetics: solid tumors and haematological malignancies
Current Vision on target enzymes for cancer therapy
Translational Cancer Genomics
FOXO family in cancer
Emerging trends in biomarker discovery: ease of prognosis and prediction in cancer
Some chinks in Ras armor: novel cancer therapeutics on the horizon
Conference - Cancer Stem Cells: impact on treatment


Should you have a proposal or an idea for a thematic issue, please complete the thematic issue proposal form and send it to the Editorial Office (Ms. Carly Middendorp, c.middendorp@elsevier.com).

Editor
Theresa Vincent
NewYork-Presbyterian Hospital/Weill Cornell Medical Center and Uppsala University, Department of Immunology, New York, United States
Editorial Advisory Board
Mariano Barbacid
Spanish National Cancer Research Centre, Madrid, Spain
Michael M Gottesman
National Cancer Institute, Bethesda, Maryland, United States
Yoshiaki Ito
National University of Singapore, Singapore, Singapore
Karol Sikora
Imperial College London Faculty of Medicine, London, United Kingdom
Robert M Sutherland
Varian Medical Systems Inc, Palo Alto, California, United States
Joyce Taylor-Papadimitriou
Cancer Research UK, London, England, United Kingdom